Longboard Pharmaceuticals, Inc. - Common Stock (NQ:LBPH)

59.98 UNCHANGED

Last Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longboard Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Crude Oil Down 2%; Tesla Deliveries Top Estimates ↗

January 02, 2024

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to...

Via Benzinga

Topics Stocks

There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target ↗

January 02, 2024

Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of...

Via Benzinga

Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today? ↗

January 02, 2024

With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 02, 2024

Via Benzinga

Dow Turns Higher; Anavex Life Sciences Shares Plunge ↗

January 02, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500...

Via Benzinga

Topics Stocks

The Latest Analyst Ratings for Longboard Pharmaceuticals ↗

October 24, 2023

Via Benzinga

The Latest Analyst Ratings for Longboard Pharmaceuticals ↗

June 27, 2023

Via Benzinga

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

Neurology-Focused Longboard Pharmaceuticals' Stock Soars Over 200% Today - Here's Why ↗

January 02, 2024

Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental

Via Benzinga

Dow Down 100 Points; US Manufacturing PMI Falls In December ↗

January 02, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ...

Via Benzinga

Topics Stocks

The Latest Analyst Ratings for Longboard Pharmaceuticals ↗

May 10, 2023

Via Benzinga

Recap: Longboard Pharmaceuticals Q1 Earnings ↗

May 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 02, 2024

Via Benzinga

Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

January 02, 2024

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

January 01, 2024

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers

November 29, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community

November 21, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 03, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results

November 02, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November

November 01, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023

October 05, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023

September 19, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals to Participate in Three Upcoming Investor Conferences

August 31, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings

August 30, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic Encephalopathies

August 23, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results

August 03, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals to Present at Upcoming Investor Conferences

August 03, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023

June 26, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

May 09, 2023

From Longboard Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2023 ↗

April 27, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.